Daily Management Review

Vertex Pharma Receives A Subpoena


A subpoena brought the Vertex Pharma’s shares into attention.

According to StreetInsider the shares of “Vertex Pharma” came into the limelight on Friday the 30th October 2015.
This incident took place once the company had “filed its 10-Q”. The said filing has demonstrated a “subpoena” in the Q3 section.
The StreetInsider quotes one portion of the filing which recounts the incident of subpoena. The extract goes like this:
“In the third quarter of 2015, we received a subpoena from the United States Department of Justice related to our marketed medicines. This subpoena requests documents relating primarily to our Good Laboratory Practices in a bioanalytical laboratory. We are in the process of responding to the subpoena and intend to cooperate”.